Antimicrobial peptide (PubMed:28275372). Is active on Mycobacterium abscessus subsp. massiliense (MBC=200 uM), a rapidly growing and emerging pathogen associated with healthcare infections (PubMed:28275372). Also shows antifungal activities (By similarity). Has a weak hemolytic activity on human erythrocytes (10% at 610 uM), indicating a low toxicity (therapeutic index (TI)=3.05) (PubMed:28275372). In addition, treatment of infected macrophages reduces the bacterial load (PubMed:28275372). In vivo, treatment of M.abscessus-infected mice causes a decrease in the bacterial load in the lungs and liver (PubMed:28275372). Has an amphipathic alpha-helical conformation. Expressed by the venom gland. Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short antimicrobial peptide (group 4) family.